nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

12.08.2018 | Original Article – Cancer Research

Fucosylation genes as circulating biomarkers for lung cancer

verfasst von: Qixin Leng, Jen-Hui Tsou, Min Zhan, Feng Jiang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Fucosyltransferases (FUTs) catalyze fucosylation, which plays a central role in biological processes. Aberrant fucosylation is associated with malignant transformation. Here we investigated whether transcriptional levels of genes coding the FUTs in plasma could provide cell-free circulating biomarkers for lung cancer.

Methods

mRNA expression of all 13 Futs (Fut1-11, Pofut1, and Pofut2) was evaluated by PCR assay in 48 lung tumor tissues and the 48 matched noncancerous lung tissues, and plasma of 64 lung cancer patients and 32 cancer-free individuals to develop plasma Fut biomarkers. The developed plasma Fut biomarkers were validated in an independent cohort of 40 lung cancer patients and 20 controls for their diagnostic performance.

Results

Four of the 13 Futs showed a different transcriptional level in 48 lung tumor tissues compared with the 48 matched nonconscious tissues (all < 0.05). Two (Fut8, and Pofut1) of the four Futs had a higher plasma level in 64 lung cancer patients compared with 32 control subjects, and consistent with that in lung tissue specimens. Combined analysis of the two Futs produced 81% sensitivity and 86% specificity for diagnosis of lung cancer, and was independent of stage and histology of lung tumors. The diagnostic performance of the two plasma biomarkers was successfully validated in the different cohort of 40 lung cancer patients and 20 control individuals.

Conclusion

The fucosylation genes may provide new circulating biomarkers for the early detection of lung cancer.

Nur mit Berechtigung zugänglich

Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395–409CrossRef

American Cancer Society (2018) Cancer facts and figures. American Cancer Society, New York

Anjuman N, Li N, Guarnera M, Stass SA, Jiang F (2013) Evaluation of lung flute in sputum samples for molecular analysis of lung cancer. Clin Transl Med 2(1):15CrossRef

Aoyagi Y, Suzuki Y, Igarashi K et al (1991) The usefulness of simultaneous determinations of glucosaminylation and fucosylation indices of alpha-fetoprotein in the differential diagnosis of neoplastic diseases of the liver. Cancer 67(9):2390–2394CrossRef

Bibbins-Domingo K, Grossman DC, Curry SJ et al (2017) Folic acid supplementation for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement. JAMA 317(2):183–189CrossRef

Breborowicz J, Mackiewicz A, Breborowicz D (1981) Microheterogeneity of alpha-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis. Scand J Immunol 14(1):15–20CrossRef

Cancer Facts & Figures (2012) American Cancer Society (ACS). J Consumer Health Internet 16(3):366–367CrossRef

Chachadi VB, Bhat G, Cheng PW (2015) Glycosyltransferases involved in the synthesis of MUC-associated metastasis-promoting selectin ligands. Glycobiology 25(9):963–975CrossRef

Chen CY, Jan YH, Juan YH et al (2013) Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer. Proc Natl Acad Sci USA 110(2):630–635CrossRef

Dodd LE, Pepe MS (2003) Partial AUC estimation and regression. Biometrics 59(3):614–623CrossRef

Dong S, Wang Z, Huang B, Zhang J, Ge Y, Fan Q (2017) Bioinformatics insight into glycosyltransferase gene expression in gastric cancer: POFUT1 is a potential biomarker. Biochem Biophys Res Commun 483(1):171–177CrossRef

Honma R, Kinoshita I, Miyoshi E et al (2015) Expression of fucosyltransferase 8 is associated with an unfavorable clinical outcome in non-small cell lung cancers. Oncology 88(5):298–308CrossRef

Hubers AJ, Prinsen CF, Sozzi G, Witte BI, Thunnissen E (2013a) Molecular sputum analysis for the diagnosis of lung cancer. Br J Cancer 109(3):530–537CrossRef

Hubers AJ, Heideman DA, Yatabe Y et al (2013b) EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study. Lung Cancer 82(1):38–43CrossRef

Humphrey LL, Deffebach M, Pappas M et al (2013) Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive Services Task Force recommendation. Ann Intern Med 159(6):411–420CrossRef

Jiang F, Todd NW, Qiu Q, Liu Z, Katz RL, Stass SA (2009) Combined genetic analysis of sputum and computed tomography for noninvasive diagnosis of non-small-cell lung cancer. Lung Cancer 66(1):58–63CrossRef

Jiang F, Todd NW, Li R, Zhang H, Fang H, Stass SA (2010) A panel of sputum-based genomic marker for early detection of lung cancer. Cancer Prev Res (Phila) 3(12):1571–1578CrossRef

Li N, Ma J, Guarnera MA, Fang H, Cai L, Jiang F (2014) Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer. J Cancer Res Clin Oncol 140(1):145–150CrossRef

Loriol C, Audfray A, Dupuy F, Germot A, Maftah A (2007) The two N-glycans present on bovine Pofut1 are differently involved in its solubility and activity. FEBS J 274(5):1202–1211CrossRef

Ma J, Jemal A, Smith R (2013a) Reply to lung cancer deaths averted by screening should be considered in the context of tobacco control policies. Cancer 119(18):3420–3421CrossRef

Ma J, Li N, Guarnera M, Jiang F (2013b) Quantification of plasma miRNAs by digital PCR for cancer diagnosis. Biomark Insights 8:127–136CrossRef

Ma J, Mannoor K, Gao L et al (2014) Characterization of microRNA transcriptome in lung cancer by next-generation deep sequencing. Mol Oncol 8(7):1208–1219CrossRef

Ma L, Dong P, Liu L et al (2016) Overexpression of protein O-fucosyltransferase 1 accelerates hepatocellular carcinoma progression via the Notch signaling pathway. Biochem Biophys Res Commun 473(2):503–510CrossRef

Marks JR, Anderson KS, Engstrom P et al (2015) Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease. Cancer Epidemiol Biomark Prev 24(2):435–441CrossRef

Moyer VA (2014) Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160(5):330–338CrossRef

Nolen BM, Lomakin A, Marrangoni A, Velikokhatnaya L, Prosser D, Lokshin AE (2015) Urinary protein biomarkers in the early detection of lung cancer. Cancer Prev Res (Phila) 8(2):111–119CrossRef

Patz EF Jr, Pinsky P, Gatsonis C et al (2014) Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 174(2):269–274CrossRef

Shen J, Liu Z, Todd NW et al (2011) Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 11:374CrossRef

Shen J, Liao J, Guarnera MA et al (2014) Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis. J Thorac Oncol 9(1):33–40CrossRef

Stahl M, Uemura K, Ge C, Shi S, Tashima Y, Stanley P (2008) Roles of Pofut1 and O-fucose in mammalian Notch signaling. J Biol Chem 283(20):13638–13651CrossRef

Su Y, Fang H, Jiang F (2016a) Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection. Clin Epigenet 8:109CrossRef

Su J, Liao J, Gao L et al (2016b) Analysis of small nucleolar RNAs in sputum for lung cancer diagnosis. Oncotarget 7(5):5131–5142CrossRef

Sullivan FX, Kumar R, Kriz R et al (1998) Molecular cloning of human GDP-mannose 4,6-dehydratase and reconstitution of GDP-fucose biosynthesis in vitro. J Biol Chem 273(14):8193–8202CrossRef

Taniguchi N, Kizuka Y (2015) Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Adv Cancer Res 126:11–51CrossRef

Travis WD (2014) The 2015 WHO classification of lung tumors. Pathologe 35(Suppl 2):188CrossRef

Tuck MK, Chan DW, Chia D et al (2009) Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res 8(1):113–117CrossRef

Wan G, Tian L, Yu Y et al (2017) Overexpression of Pofut1 and activated Notch1 may be associated with poor prognosis in breast cancer. Biochem Biophys Res Commun 491(1):104–111CrossRef

Wu LH, Shi BZ, Zhao QL, Wu XZ (2010) Fucosylated glycan inhibition of human hepatocellular carcinoma cell migration through binding to chemokine receptors. Glycobiology 20(2):215–223CrossRef

Xie Y, Todd NW, Liu Z et al (2010) Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 67(2):170–176CrossRef

Xing L, Todd NW, Yu L, Fang H, Jiang F (2010) Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol 23(8):1157–1164CrossRef

Xing L, Su J, Guarnera MA et al (2015) Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules. Clin Cancer Res 21(2):484–489CrossRef

Yu L, Todd NW, Xing L et al (2010) Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer 127(12):2870–2878CrossRef

Zhou W, Ma H, Deng G, Tang L, Lu J, Chen X (2017) Clinical significance and biological function of fucosyltransferase 2 in lung adenocarcinoma. Oncotarget 8(57):97246–97259CrossRef

Titel: Fucosylation genes as circulating biomarkers for lung cancer
verfasst von: Qixin Leng
Jen-Hui Tsou
Min Zhan
Feng Jiang
Publikationsdatum: 12.08.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 11/2018
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-018-2735-0

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Fucosylation genes as circulating biomarkers for lung cancer

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2018

The impact of different doses of indocyanine green on the sentinel lymph-node mapping in early stage endometrial cancer

Locally advanced gastric cancer: total iodine uptake to predict the response of primary lesion to neoadjuvant chemotherapy

Clinical utility of assessing PTEN and ERG protein expression in prostate cancer patients: a proposed method for risk stratification

Variability in HER2 expression between primary colorectal cancer and corresponding metastases

Middle East observational study in metastatic soft tissue sarcoma: an epidemiological study on the treatment patterns (MOON)

Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review and meta-analysis

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie